Trial
NCT03943446
A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After Surgery
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Takeda
Collaborators
Takeda Development Center Americas, Inc.
Condition
Crohn Disease
Intervention
TAK-018
Why stopped
Sponsor decision to discontinue study due to inability to recruit the expected number of subjects within the requisite time period.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-07